ArticleEndocrine oncology (Bristol, England)2023

Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation.

Prabesh Khatiwada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.